or Try an Advanced Search...

    Monogenic Stocks List

    Symbol Grade Name % Change
    RYTM C Rhythm Pharmaceuticals, Inc. -0.40
    SGMO C Sangamo BioSciences, Inc. 1.51
    TSHA C Taysha Gene Therapies, Inc. 1.00
    PASG F Passage Bio, Inc. 0.00
    VYGR F Voyager Therapeutics, Inc. 1.12
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Gene Therapy Huntington's Disease Life Sciences Lipid Storage Disorders Medicine Monogenic Diseases Organ Systems Rare Diseases Amyotrophic Lateral Sclerosis Ataxia Biopharmaceutical Blastoma Cell Product Central Nervous System Disorders Deficiency Deficiency Syndrome Dow Agrosciences Emerging Technologies Friedreich's Ataxia

    Related ETFs - A few ETFs which own one or more of the above listed Monogenic stocks.

    Symbol Grade Name Weight
    OZEM F Roundhill GLP-1 & Weight Loss ETF 2.3
    BBP C BioShares Biotechnology Products Fund 2.07
    QQQS C Invesco NASDAQ Future Gen 200 ETF 2.05
    HAPS B Harbor Corporate Culture Small Cap ETF 1.76
    BMED D BlackRock Future Health ETF 1.48
    View all Monogenic ETFs...
    Compare ETFs
    Compare OZEM to BBP Compare OZEM to QQQS Compare QQQS to BMED

        Monogenic Stocks Recent News

        Date Stock Title
        Nov 20 VYGR Voyager selects gene therapy development candidate for Alzheimer’s disease
        Nov 20 VYGR Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
        Nov 19 SGMO Sangamo stock climbs 12% post-market on FDA update for ST-503
        Nov 19 SGMO Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain
        Nov 18 RYTM Biotech Stock Attempts To End Losing Streak, Lands Back in Buy Zone
        Nov 18 VYGR Voyager Therapeutics' Tracer Platform Targets CNS Market: Here's Why I'm Neutral
        Nov 18 RYTM Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide
        Nov 15 TSHA Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 15 SGMO Sangamo Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 14 TSHA Q3 2024 Taysha Gene Therapies Inc Earnings Call
        Nov 14 RYTM Rhythm releases positive Imcivree data for younger age group
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Gene Therapy Huntington's Disease Life Sciences Lipid Storage Disorders Medicine Monogenic Diseases Organ Systems Rare Diseases Amyotrophic Lateral Sclerosis Ataxia Biopharmaceutical Blastoma Cell Product Central Nervous System Disorders Deficiency Deficiency Syndrome Dow Agrosciences Emerging Technologies Friedreich's Ataxia
        Monogenic

        Browse All Tags